DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix
Floortje J. Backes, Liam Il‐Young Chung, David M. O’Malley, Robinson Wr et al.
Journal
Journal for ImmunoTherapy of Cancer
Topics
Cancer Immunotherapy and Biomarkers
article
DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix
Floortje J. Backes, Liam Il‐Young Chung, David M. O’Malley, Robinson Wr, Charles D. Blanke, Mihaela Cristea, Anthony J. Jaslowski, Kwang Chae Young, Hussein Moustapha Ali-Ahmad, Jessica Thomes Pepin, Katherine C. Kurnit, Ramez N. Eskander, Sandip Pravin Patel, Jean Siedel, Elad Sharon, Christine M. McLeod, HOWARD Z. STREICHER, Edward Kim, Colleen McCormick, S. Goodrich, Thanasak Sueblinvong, Carolyn Moloney-Lineen, John Chan, Helen X Chen, Hye Sung Kim, Aung Naing, Razelle Kurzrock, Justin Neal Bottsford-Miller, Seth Olusegun Fagbemi, John Hays, Jennifer Scalici, Megan Othus, Christopher W Ryan, Amina Ahmed
article en
Abstract
No abstract available for this paper.
Publication Tag
Journal for ImmunoTherapy of CancerVol. 14(2)
Institutions
Northwestern University (US), Tulane University (US), Rush University Medical Center (US), Marshfield Clinic (US), Kaiser Permanente (US), The University of Texas MD Anderson Cancer Center (US), Oregon Health & Science University (US), Medical College of Wisconsin (US), Montana State University (US), University of Michigan (US), Legacy Good Samaritan Medical Center (US), California Pacific Medical Center (US), University of California San Diego (US), University of Chicago (US), USA Mitchell Cancer Institute (US), Montana Molecular (United States) (US), Comprehensive OBGYN (US), Kaiser Foundation Hospital (US), City of Hope (US), Temple University Hospital (US), Michigan Cancer Research Consortium (US), Montana Bible College (US), Regional Medical Center (US), National Cancer Institute (US), Parkview Health (US), Kaiser Permanente Moanalua Medical Center (US), Hawaii Permanente Medical Group (US), SWOG Cancer Research Network (US), Minnesota Oncology (US), The Ohio State University (US), University of California, Davis (US)
Funders
Bristol-Myers Squibb, Northwestern University, National Institutes of Health, National Cancer Institute